Completed OBSERVATIONAL NCT03937245

Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care (EurobactII)

Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care: the Eurobact II Multinational Cohort Study

Sponsor: European Society of Clinical Microbiology and Infectious Diseases

Conditions Bacteremia Hospital Acquired Condition Resistance Bacterial Sepsis

Updated 6 times since 2019 Last updated: Sep 8, 2021 Started: Aug 30, 2019 Primary completion: Jun 2, 2021 Completion: Jun 3, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Bacteremia and Hospital Acquired Condition and is currently completed. European Society of Clinical Microbiology and Infectious Diseases leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Oct 2021 [monthly]

Recruiting
Dec 2019 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2019 — Dec 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Society of Clinical Microbiology and Infectious Diseases
European Society of Intensive Care Medicine
Institut National de la Santé Et de la Recherche Médicale, France
Outcome Rea

Data source: Outcome Rea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brisbane, Australia
• Paris, France